Mirum Pharmaceuticals Inc. (NASDAQ: MIRM) and Incyte Corp. (NASDAQ: INCY) announced positive results from a phase 2 study of zilurgisertib ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE